Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns
#3PRI RANKED
Most Cited Paper
in Dialysis and Renal Disease Management
18 Months Post-Publication
Class of 2026
“Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/dialysis-and-renal-disease-management/2026/
Topics
KDIGO Clinical Practice Guideline · Chronic kidney disease · glomerular filtration rate (GFR) · Serum creatinine · Cystatin C · Urinary albumin measurement · GRADE methodology · Chronic kidney disease progression · kidney biopsy · risk prediction models · Sodium-glucose cotransporter 2 inhibitors · renin-angiotensin system inhibitors · medication management · drug stewardship · Dialysis · Kidney transplantation · laboratory standardization · CKD etiology · molecular diagnostics
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Dialysis and Renal Disease Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/dialysis-and-renal-disease-management/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459